H Lundbeck A/S

H Lundbeck A/S OCF Margin

The Operating Cash Flow Margin of H Lundbeck A/S (LUN.CO) as of Oct 14, 2026 is 20.11 %. In the previous year, Operating Cash Flow Margin was 15.12 % — a change of 33.07% (higher).

OCF Margin

20.11 %

YoY

33.07%

Last updated:

Operating Cash Flow Margin of H Lundbeck A/S is 2025 20.11 % . Operating Cash Flow Margin of H Lundbeck A/S was 2024 15.12 % . It decreases by 33.07% higher compared to the previous year.

The H Lundbeck A/S OCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF Margin
Date
OCF Margin
Jan 1, 2018
33.46 DKK
Jan 1, 2019
15.03 DKK
Jan 1, 2020
21.72 DKK
Jan 1, 2021
13.94 DKK
Jan 1, 2022
19.29 DKK
Jan 1, 2023
20.49 DKK
Jan 1, 2024
15.12 DKK
Jan 1, 2025
20.11 DKK
The H Lundbeck A/S OCF Margin history
YEAROCF MarginYoY
20.11 %+33.07%
15.12 %-26.23%
20.49 %+6.24%
19.29 %+38.36%
13.94 %-35.82%
21.72 %+44.50%
15.03 %-55.08%
33.46 %+42.56%
23.47 %+17.39%
19.99 %+1,381.25%
1.35 %-88.71%
11.95 %—
Access this data via the Eulerpool API
Get Free API Key

H Lundbeck A/S Stock analysis

What does H Lundbeck A/S do? H Lundbeck A/S is a Danish company that was founded in 1915 by Hans Lundbeck. Since its inception, the company has focused on researching and developing medications that improve the lives of people with neuropsychiatric disorders. Lundbeck's business model is based on a clear strategy and a strong focus on the research and development of pharmaceuticals. The company has four main therapy areas: depression, anxiety disorders, Alzheimer's, and Parkinson's. Lundbeck products are sold in over 100 countries worldwide and are known for their effectiveness and high quality. Over the years, Lundbeck has also focused on developing innovative treatment methods, including research on new drugs and therapies based on neurotransmitters such as serotonin, dopamine, and norepinephrine. With the acquisition of Alder BioPharmaceuticals in 2019, Lundbeck also expanded its portfolio in the field of migraine therapy. Some of Lundbeck's most well-known products include Lexapro, Cipralex, Selincro, Abilify Maintena, and Brintellix. These medications are used in the treatment of depression, anxiety disorders, alcoholism, bipolar disorders, and migraines. In addition to selling medications, Lundbeck also provides training and support for healthcare professionals and patients. Lundbeck is also distinguished by its commitment to social engagement and works closely with nonprofit organizations to raise awareness of neuropsychiatric disorders. The company has also launched various programs to improve access to medical care in particularly affected regions. In 2020, Lundbeck exceeded 18,000 employees worldwide and had a revenue of 16.6 billion Danish kroner. Lundbeck is listed on NASDAQ OMX Copenhagen and is controlled by the Lundbeck Foundation, which holds over 70% of the company's ownership. In summary, Lundbeck is a leading company in the field of neuropsychiatric medicine and is dedicated to improving the lives of people with these serious disorders. The company has made a name for itself through its successful research and development of therapies and medications, as well as its strong focus on social engagement and corporate social responsibility. H Lundbeck A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about H Lundbeck A/S stock

Operating Cash Flow Margin of H Lundbeck A/S is 20.11 % in 2025.

Operating Cash Flow Margin of H Lundbeck A/S changed from 15.12 % to 20.11 %, representing a 33.07% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Margin H Lundbeck A/S since 2006 – with annual values, charts, and detailed analysis.

OCF margin measures the percentage of revenue converted into operating cash flow. It indicates cash generation efficiency from core business operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow Margin's H Lundbeck A/S with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Cash Flow Margin.

Access this data via the Eulerpool API
Get Free API Key

Margins — H Lundbeck A/S

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — H Lundbeck A/S